Personalized Adaptive Radiotherapy for Hepatocellular Carcinoma | MicrobiomeTrials← Back to trialsNCT07895732
Personalized Adaptive Radiotherapy for Hepatocellular Carcinoma
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-12-01Est. Completion: 2031-12-01
Enrollment target: 60 participants Locations- Princess Margaret Cancer Center, Toronto, Ontario, Canada
Other microbiome trials you might be interested in
Hepatocellular Carcinoma Non-Resectable
Each year, approximately 1,000 patients in the Netherlands are diagnosed with liver cancer. When liver cancer can no lon…
Nijmegen, NetherlandsEst. completion Sep 2028
Hepatocellular CarcinomaHCC
This is a phase 2 single-arm, open-label clinical trial determining efficacy of cabozantinib in combination with ipilimu…
Orange, United StatesEst. completion Jan 31, 2027